{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T18:20:41Z","timestamp":1794680441421,"version":"4.9.1"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>The Botswana Tsepamo study identified an initial neural tube defect (NTD) safety signal with dolutegravir antiretroviral therapy (ART) exposure at conception. We conducted similar surveillance in 5 hospitals in Eswatini from September 2021 to September 2023 to evaluate the prevalence of birth defects and adverse pregnancy outcomes by maternal HIV status and ART regimen\/timing.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Routine pregnancy history and HIV\/ART status were collected from clinic records. Women of live or stillborn infants with birth defects consented for interviews and photographs of defects. A medical geneticist reviewed blinded interview data and photographs.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Of 45,836 women with live-born or stillborn infants, 13,577 (29.6%) were living with HIV; 11,581 (86.0%) were receiving ART at conception (84.1% dolutegravir). Overall, birth defects were confirmed in 387 (0.8%) women. Comparing women with and without HIV, there were no significant differences in major defects (0.48% vs. 0.38%) or NTD (0.10% vs. 0.08%). In women with HIV, there were no significant differences between those on dolutegravir versus non-dolutegravir at conception for major defects (0.53% vs. 0.49%) or NTD (0.08% vs. 0.22%). Stillbirths were significantly higher in women with HIV than those without (2.6% vs. 1.9%, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001), as was low birthweight and preterm delivery (11.8% vs. 10.4%, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001; 12.5% vs. 10.7%, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001, respectively). There were no significant differences in outcomes by ART regimen.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>While these data from sub-Saharan Africa further strengthen the lack of a NTD safety signal in women with HIV on ART, there remained elevated adverse birth outcomes despite treatment compared to women without HIV.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000004745","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T14:01:44Z","timestamp":1738591304000},"page":"431-438","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["Birth Defects and Adverse Pregnancy Outcomes in Hospital-based Birth Surveillance in Eswatini"],"prefix":"10.1097","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7391-6947","authenticated-orcid":false,"given":"Michelle M.","family":"Gill","sequence":"first","affiliation":[{"name":"Elizabeth Glaser Pediatric AIDS Foundation, Washington, District of Colombia and Mbabane, Eswatini"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philisiwe Ntombenhle","family":"Khumalo","sequence":"additional","affiliation":[{"name":"Elizabeth Glaser Pediatric AIDS Foundation, Washington, District of Colombia and Mbabane, Eswatini"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather J.","family":"Hoffman","sequence":"additional","affiliation":[{"name":"George Washington University, Milken Institute School of Public Health, Washington, District of Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caspian","family":"Chouraya","sequence":"additional","affiliation":[{"name":"Elizabeth Glaser Pediatric AIDS Foundation, Washington, District of Colombia and Mbabane, Eswatini"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mthokozisi","family":"Kunene","sequence":"additional","affiliation":[{"name":"Elizabeth Glaser Pediatric AIDS Foundation, Washington, District of Colombia and Mbabane, Eswatini"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Futhi","family":"Dlamini","sequence":"additional","affiliation":[{"name":"Elizabeth Glaser Pediatric AIDS Foundation, Washington, District of Colombia and Mbabane, Eswatini"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Tukei","sequence":"additional","affiliation":[{"name":"Elizabeth Glaser Pediatric AIDS Foundation, Washington, District of Colombia and Mbabane, Eswatini"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela E.","family":"Scheuerle","sequence":"additional","affiliation":[{"name":"University of Texas Southwestern Medical Center Dallas, Dallas, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonisile","family":"Nhlabatsi","sequence":"additional","affiliation":[{"name":"Sexual and Reproductive Health Unit, Ministry of Health, Mbabane, Eswatini."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne","family":"Mofenson","sequence":"additional","affiliation":[{"name":"Elizabeth Glaser Pediatric AIDS Foundation, Washington, District of Colombia and Mbabane, Eswatini"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,2,3]]},"reference":[{"key":"R1-20250514","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1056\/NEJMc1807653","article-title":"Neural-tube defects with dolutegravir treatment from the time of conception.","volume":"379","author":"Zash","year":"2018","journal-title":"N Engl J Med"},{"key":"R2-20250514","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/S0140-6736(18)31265-0","article-title":"Dolutegravir for HIV: a lesson in pregnancy safety research.","volume":"391","year":"2018","journal-title":"Lancet"},{"key":"R3-20250514","article-title":"New study suggests risk of birth defects in babies born to women on HIV medicine dolutegravir.","year":"2018"},{"key":"R4-20250514","article-title":"FDA Drug Safety Communication: FDA to evaluate potential risk of neural tube birth defects with HIV medicine dolutegravir (Juluca, Tivicay, Triumeq).","year":"2018"},{"key":"R5-20250514","doi-asserted-by":"crossref","first-page":"e25352","DOI":"10.1002\/jia2.25352","article-title":"Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defects.","volume":"22","author":"Mofenson","year":"2019","journal-title":"J Int AIDS Soc"},{"key":"R7-20250514","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1001\/jama.2023.9864","article-title":"Folic acid supplementation to prevent neural tube defects: updated evidence report and systematic review for the US Preventive Services Task Force.","volume":"330","author":"Viswanathan","year":"2023","journal-title":"JAMA"},{"key":"R8-20250514","article-title":"Population based HIV Impact Assessment (PHIA).","year":"2022"},{"key":"R9-20250514","article-title":"Eswatini Multiple Indicator Cluster Survey (MICS) 2021-2022: survey findings report.","year":"2024"},{"key":"R11-20250514","doi-asserted-by":"crossref","first-page":"ofad441","DOI":"10.1093\/ofid\/ofad441","article-title":"Strengthening the evidence: similar rates of neural tube defects among deliveries regardless of maternal HIV status and dolutegravir exposure in hospital birth surveillance in Eswatini.","volume":"10","author":"Gill","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"R12-20250514","article-title":"Metropolitan Atlanta Congenital Defects Program (MACDP)."},{"issue":"Suppl 1","key":"R14-20250514","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/1471-2393-10-S1-S1","article-title":"Global report on preterm birth and stillbirth (1 of 7): definitions, description of the burden and opportunities to improve data.","volume":"10","author":"Lawn","year":"2010","journal-title":"BMC Pregnancy Childbirth"},{"key":"R15-20250514","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1186\/s12884-019-2542-x","article-title":"A hospital-based birth defects surveillance system in Kampala, Uganda.","volume":"19","author":"Mumpe-Mwanja","year":"2019","journal-title":"BMC Pregnancy Childbirth"},{"key":"R17-20250514","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1186\/s12909-023-04760-w","article-title":"Strengthening capacity of health workers to diagnose birth defects in Ugandan hospitals from 2015 to 2021.","volume":"23","author":"Namale-Matovu","year":"2023","journal-title":"BMC Med Educ"},{"key":"R18-20250514","doi-asserted-by":"crossref","first-page":"971","DOI":"10.4102\/sajhivmed.v20i1.971","article-title":"Birth outcomes following antiretroviral exposure during pregnancy: initial results from a pregnancy exposure registry in South Africa.","volume":"20","author":"Mehta","year":"2019","journal-title":"South Afr J HIV Med"},{"key":"R19-20250514","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1056\/NEJMoa1905230","article-title":"Neural-tube defects and antiretroviral treatment regimens in Botswana.","volume":"381","author":"Zash","year":"2019","journal-title":"N Engl J Med"},{"key":"R20-20250514","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/bdr2.1887","article-title":"Limited surface examination to evaluate potential teratogens in a resource-limited setting.","volume":"113","author":"Holmes","year":"2021","journal-title":"Birth Defects Res"},{"key":"R21-20250514","article-title":"Texas Birth Defects Registry (TBDR) Annual Report - birth defects among 1999-2020 deliveries."},{"key":"R22-20250514","doi-asserted-by":"crossref","first-page":"e5801","DOI":"10.1002\/pds.5801","article-title":"The Antiretroviral Pregnancy Registry: three decades of prospective monitoring for birth defects.","volume":"33","author":"Albano","year":"2024","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R23-20250514","doi-asserted-by":"crossref","first-page":"e588","DOI":"10.1016\/S2352-3018(23)00108-X","article-title":"Dolutegravir and pregnancy outcomes including neural tube defects in the USA during 2008-20: a national cohort study.","volume":"10","author":"Kourtis","year":"2023","journal-title":"Lancet HIV"},{"key":"R24-20250514","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0140-6736(21)01112-0","article-title":"Global, regional, and national estimates and trends in stillbirths from 2000 to 2019: a systematic assessment.","volume":"398","author":"Hug","year":"2021","journal-title":"Lancet"},{"key":"R25-20250514","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1093\/ije\/dyab248","article-title":"Prevalence, risk factors and short-term consequences of adverse birth outcomes in Zimbabwean pregnant women: a secondary analysis of a cluster-randomized trial.","volume":"51","author":"Chasekwa","year":"2022","journal-title":"Int J Epidemiol"},{"key":"R26-20250514","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/frph.2021.672446","article-title":"Pooled prevalence of adverse pregnancy and neonatal outcomes in Malawi, South Africa, Uganda, and Zimbabwe: results from a systematic review and meta-analyses to inform trials of novel HIV prevention interventions during pregnancy.","volume":"3","author":"Lokken","year":"2021","journal-title":"Front Reprod Health"},{"key":"R27-20250514","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12978-020-01029-z","article-title":"Rates and risk factors for preterm birth and low birthweight in the global network sites in six low- and low middle-income countries.","volume":"17","author":"Pusdekar","year":"2020","journal-title":"Reprod Health"},{"key":"R28-20250514","doi-asserted-by":"crossref","first-page":"e0248423","DOI":"10.1371\/journal.pone.0248423","article-title":"Assessing pregnancy and neonatal outcomes in Malawi, South Africa, Uganda, and Zimbabwe: results from a systematic chart review.","volume":"16","author":"Balkus","year":"2021","journal-title":"PLoS One"},{"key":"R30-20250514","doi-asserted-by":"crossref","first-page":"e172222","DOI":"10.1001\/jamapediatrics.2017.2222","article-title":"Comparative safety of antiretroviral treatment regimens in pregnancy.","volume":"171","author":"Zash","year":"2017","journal-title":"JAMA Pediatr"},{"key":"R31-20250514","doi-asserted-by":"crossref","first-page":"e071205","DOI":"10.1136\/bmjopen-2022-071205","article-title":"Association between maternal HIV infection and the risks of preterm birth and low birth weight in Chengdu, China: a propensity score matching approach.","volume":"13","author":"Yingjuan","year":"2023","journal-title":"BMJ Open"},{"key":"R32-20250514","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/aogs.14282","article-title":"Perinatal outcomes in women living with HIV-1 and receiving antiretroviral therapy-a systematic review and meta-analysis.","volume":"101","author":"Shinar","year":"2022","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R33-20250514","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/QAD.0000000000004032","article-title":"Adverse perinatal outcomes associated with different classes of antiretroviral drugs in pregnant women living with HIV: a systematic review and meta-analysis.","volume":"39","author":"Hey","year":"2024","journal-title":"AIDS"},{"key":"R34-20250514","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/QAD.0000000000003728","article-title":"Maternal and birth outcomes in pregnant people with and without HIV in the Western Cape, South Africa.","volume":"38","author":"Slogrove","year":"2024","journal-title":"AIDS"},{"key":"R35-20250514","doi-asserted-by":"crossref","first-page":"e13497","DOI":"10.1111\/aji.13497","article-title":"Using principal component analysis to examine associations of early pregnancy inflammatory biomarker profiles and adverse birth outcomes.","volume":"86","author":"Keenan-Devlin","year":"2021","journal-title":"Am J Reprod Immunol"},{"key":"R36-20250514","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1080\/14767058.2017.1297404","article-title":"Biomarkers for predicting spontaneous preterm birth: an umbrella systematic review.","volume":"31","author":"Lucaroni","year":"2018","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R37-20250514","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1097\/QAD.0000000000003546","article-title":"Mechanisms of systemic low-grade inflammation in HIV patients on long-term suppressive antiretroviral therapy: the inflammasome hypothesis.","volume":"37","author":"Guerville","year":"2023","journal-title":"AIDS"},{"key":"R38-20250514","doi-asserted-by":"crossref","first-page":"101471","DOI":"10.1016\/j.smim.2021.101471","article-title":"Residual immune dysfunction under antiretroviral therapy.","volume":"51","author":"Cai","year":"2021","journal-title":"Semin Immunol"},{"key":"R39-20250514","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1097\/QAD.0000000000003016","article-title":"Impact of HIV status on systemic inflammation during pregnancy.","volume":"35","author":"Vyas","year":"2021","journal-title":"AIDS"},{"key":"R40-20250514","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1093\/infdis\/jiac501","article-title":"Unique profile of inflammation and immune activation in pregnant people with HIV in the United States.","volume":"227","author":"Shiau","year":"2023","journal-title":"J Infect Dis"},{"key":"R41-20250514","doi-asserted-by":"crossref","first-page":"1165964","DOI":"10.3389\/fimmu.2023.1165964","article-title":"Persistent immune activation and altered gut integrity over time in a longitudinal study of Ugandan youth with perinatally acquired HIV.","volume":"14","author":"Dirajlal-Fargo","year":"2023","journal-title":"Front Immunol"},{"key":"R42-20250514","doi-asserted-by":"crossref","first-page":"e2140584","DOI":"10.1001\/jamanetworkopen.2021.40584","article-title":"Association of maternal inflammation during pregnancy with birth outcomes and infant growth among women with or without HIV in India.","volume":"4","author":"Shafiq","year":"2021","journal-title":"JAMA Network Open"},{"key":"R43-20250514","doi-asserted-by":"crossref","first-page":"10980","DOI":"10.1038\/s41598-024-61764-2","article-title":"Distinct cytokine profiles in late pregnancy in Ugandan people with HIV.","volume":"14","author":"Bebell","year":"2024","journal-title":"Sci Rep"},{"key":"R44-20250514","doi-asserted-by":"crossref","first-page":"10079","DOI":"10.1038\/s41598-021-89551-3","article-title":"Maternal HIV infection is associated with distinct systemic cytokine profiles throughout pregnancy in South African women.","volume":"11","author":"Akoto","year":"2021","journal-title":"Sci Rep"},{"key":"R45-20250514","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.placenta.2020.12.004","article-title":"Exploring the impact of HIV infection and antiretroviral therapy on placenta morphology.","volume":"104","author":"Yampolsky","year":"2021","journal-title":"Placenta"},{"key":"R46-20250514","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/S2352-3018(15)00207-6","article-title":"Perinatal outcomes associated with maternal HIV infection: a systematic review and meta-analysis.","volume":"3","author":"Wedi","year":"2016","journal-title":"Lancet HIV"},{"key":"R47-20250514","first-page":"e2020022","article-title":"Overcoming staffing challenges when implementing a birth defects surveillance system: a Ugandan experience.","volume":"4","author":"Namale-Matovu","year":"2020","journal-title":"J Glob Health Rep"},{"key":"R48-20250514","doi-asserted-by":"crossref","first-page":"e0173800","DOI":"10.1371\/journal.pone.0173800","article-title":"Detecting congenital malformations - lessons learned from the Mpepu study, Botswana.","volume":"12","author":"Ajibola","year":"2017","journal-title":"PLoS One"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004745","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T21:13:06Z","timestamp":1747257186000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,3]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004745","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,3]]}}}